Asthma decisions — 2017

The Veteran's asthma is not productive of any respiratory symptomatology, and his service-connected condition does not meet the criteria for a higher rating.

The Board has remanded the case for additional development to address the Veteran's lung conditions and their relationship to service, including exposure to asbestos.

The Veteran's asthma, irritable bowel syndrome, and interstitial cystitis have been granted service connection as new and material evidence has been received.

The Veteran's claim for service connection for a respiratory disability, including asthma, emphysema, and interstitial lung disease, is being remanded due to the need for additional development and an updated VA opinion.

The Veteran's asthma and sleep apnea were rated at 30 percent prior to June 1, 2004. As of June 1, 2004, the Veteran is entitled to a rating of 60 percent for his asthma and sleep apnea.

The Veteran's claims for a higher rating for bronchial asthma and TDIU are being remanded due to the need for additional development of his medical records.

The Veteran's son, C.N.F., was found to be permanently incapable of self-support due to physical conditions prior to reaching the age of 18. The Board granted the claim based on this finding.

The Veteran's asthma with chronic allergic rhinitis is currently rated at 10 percent, and the Board finds that a higher rating is not warranted.

The Veteran's claimed respiratory disabilities (asthma, emphysema, COPD and pneumonia) were not shown to be related to his active duty service.

The Veteran's claim for reimbursement of private medical expenses incurred on October 6, 2015 was denied as the condition did not qualify as a medical emergency and therefore does not meet the criteria for reimbursement under VA regulations.

The Veteran's asthma warrants a rating of 60 percent effective February 13, 2015. The RO has granted this higher rating since December 9, 2011.

The Veteran's claim for service connection for a lung condition, including COPD, asthma, bronchitis, and pulmonary hypertension is being remanded due to the need for additional development regarding whether he has pulmonary hypertension related to his military service.

The Veteran's asthma was found to have existed prior to service and not aggravated by service. The left knee disability is denied as well, with the Veteran scheduled for a VA examination to determine its current severity.

The Veteran's asthma rating is being remanded for additional development, including a new VA examination and the provision of his medical records from 'JFK Hospital'. The current nature and severity of his service-connected asthma will be evaluated.

The Veteran's asthma and PTSD have been granted service connection, but the effective date for the PTSD rating remains denied.

The Veteran's lung disability is presumed to be due to his exposure to herbicide agents during service. The Board grants service connection for COPD, pneumonia, and asthma.

The Veteran's appeal for increased ratings for her respiratory disability and TDIU prior to November 17, 2016 is being remanded due to the need to determine the appropriate diagnostic code based on the predominant respiratory disability. The AOJ must also consider whether an effective date earlier than November 17, 2016 should be assigned for granting a TDIU.

The Veteran's claim for service connection for a respiratory disorder, including bronchitis/asthma, is being remanded due to the need for additional development of his medical records and an updated VA examination.

The Board has determined that a remand is necessary to obtain an adequate VA opinion regarding the cause of the Veteran's death and whether his service-connected bronchial asthma with emphysema contributed substantially or materially to it. Additionally, the Appellant must provide any outstanding private medical records related to her husband's treatment at Alpha Home Health & Hospice.

The Veteran's bronchial asthma is rated at a 30 percent since May 17, 2012. Prior to that date, the evidence shows his condition required daily inhalational bronchodilator therapy.